If you have been using 7-OH and you are starting or already taking Suboxone, treatment is still open to you, and the thing your care team most needs to get right is timing. 7-OH is a potent opioid, so beginning Suboxone therapy too soon after a dose can set off precipitated withdrawal.
7-OH is a concentrated opioid made from kratom. It is not a byproduct of Suboxone, it does not appear on a routine opioid drug screen, and starting buprenorphine too early after using it can trigger precipitated withdrawal. Telling your clinician what you have actually been taking is what makes a safe start possible.
7-OH is short for 7-hydroxymitragynine, an alkaloid found in trace amounts in the kratom plant and concentrated or synthesized for the products sold in gas stations, smoke shops, and vape stores. The U.S. Food and Drug Administration describes it plainly: 7-OH is an opioid that can be more potent than morphine.
Tablets, gummies, shots, and drink mixes are the usual formats.
People often find it while trying to get off something else. A tablet bought legally at a counter can feel like a safer bridge than what came before it, right up until the dose stops holding and the gaps between doses start to hurt.
None of that makes you a bad candidate for medication. It makes you someone whose clinician needs the real picture. We have written separately about why kratom and 7-OH fall short as a way to manage opioid withdrawal.
A lot of confusion comes from the abbreviation itself, which looks like it could belong to any number of compounds. It does not belong to buprenorphine, and no buprenorphine metabolite goes by that name.
| Term | What It Is | Where It Comes From |
| 7-OH (7-hydroxymitragynine) | A potent opioid, more potent than morphine per the FDA | The kratom plant, concentrated or synthesized in commercial products |
| Mitragynine | The primary alkaloid in kratom leaf | The kratom plant |
| Buprenorphine | The partial opioid agonist in Suboxone | A prescription medication |
| Norbuprenorphine | The main metabolite labs report on a buprenorphine panel | Your body breaking down buprenorphine |
If a lab report lists 7-OH, it is telling you a kratom-derived opioid was found. It is not telling you your Suboxone is working.
Buprenorphine binds to opioid receptors very tightly and only partially activates them. When it arrives while a fuller opioid such as 7-OH is still occupying those receptors, it displaces that opioid and drops the total signal fast. The result is precipitated withdrawal, which comes on within an hour or two and feels considerably worse than ordinary withdrawal.
Avoiding it is a timing problem, and timing depends on what you took, how much, and when. That is the entire reason your clinician asks.
Nobody is building a case against you.
Your care team may use a structured withdrawal measure such as the Clinical Opiate Withdrawal Scale, a short standardized checklist of withdrawal signs, to decide when the window has opened. Some people are started at a low dose and stepped up slowly instead.
Not on a routine one. Standard opioid immunoassay panels are built to flag morphine-type opiates and a handful of specific synthetics, and kratom alkaloids are not among them. Detecting 7-OH or mitragynine takes a separate, targeted order, which reference laboratories offer as a standalone mitragynine test run by mass spectrometry.
| Test | What It Covers | What It Will Not Tell You |
| Routine opioid immunoassay | Morphine-type opiates, plus selected synthetics depending on the panel | Whether 7-OH or mitragynine is present |
| Buprenorphine panel | Buprenorphine and norbuprenorphine, confirming your prescription | Anything about kratom-derived opioids |
| Targeted mitragynine testing (LC-MS/MS) | Kratom alkaloids, ordered specifically | Results are slower, and the test must be requested |
Two practical consequences follow:
Readers sometimes arrive here from the opposite question, how Suboxone itself shows up on a drug test, and the same principle holds in both directions.
The honest summary is that the interview matters more than the cup.
Published case reports and case series in the addiction medicine literature describe buprenorphine and naloxone being used to treat kratom dependence and withdrawal, with patients stabilized on standard maintenance dosing. More recent reports address concentrated 7-OH specifically. The body of evidence is small, and it is real.
What it supports is modest and useful. Buprenorphine is a reasonable, evidence-informed option for people whose dependence involves kratom or its concentrated derivatives, prescribed and monitored the same way it would be for any other opioid. What it does not support is any promise about how a given person will do.
Your clinician weighs several things alongside the opioid picture:
Medication for addiction treatment works best when the rest of that picture is on the table too. If cocaine is part of that picture, our guide on whether buprenorphine can help with cocaine use explains what the medication can and cannot do.
Bringing a photo ID, a current medication list, and any recent lab reports speeds the visit considerably. Nothing on that list is a requirement for being seen, and opioid use disorder treatment can begin the same day when your clinician judges it safe.
A positive result is information, not a verdict. It does not automatically end your prescription, and it is not a reason to stop coming in.
What it usually prompts is a conversation about whether your current dose is holding you, whether cravings are being managed, and whether something in your life shifted. Any of these would be a normal response:
Disappearing is the one response that reliably makes things worse. Ask for the appointment.
In July 2026 the Drug Enforcement Administration announced it would temporarily place concentrated 7-OH and three related substances in Schedule I, a control that runs two years with a possible one-year extension. The order applies above a specified concentration threshold rather than to botanical kratom leaf.
Product availability is therefore changing, and people who relied on a steady supply may find it gone. Nothing about that changes your ability to get treatment.
Porch Light Health delivers care three ways, which matters when transportation or work schedules are part of the problem. In-person clinics, mobile medical units, and telehealth appointments all lead to the same clinical team.
Telehealth can carry a first visit in many situations, with a local sample collection arranged when testing is needed. Requirements vary by state and by your circumstances, so ask when you call rather than assuming either way.
Ready to talk to someone? Call 866-839-8868 or contact Porch Light Health to start care. Medicaid and Medicare are accepted, along with major commercial plans, and a sliding-fee program is available for people who need it.
Is 7-OH the same thing as the 7-OH on my Suboxone lab report?
No. Buprenorphine panels report buprenorphine and norbuprenorphine, not 7-OH. A 7-OH result refers to 7-hydroxymitragynine, a kratom-derived opioid, and it is reported only when someone specifically orders that test.
Can I start Suboxone if I have only been using 7-OH and nothing else?
Yes, in many cases. Opioid dependence from concentrated 7-OH is treated like other opioid dependence, and your clinician will focus on how long it has been since your last dose and how your withdrawal is presenting.
Will using 7-OH get me discharged from treatment?
No. Porch Light Health treats a positive result as clinical information and responds by adjusting the plan. Continuing care through a setback is the point of outpatient treatment.
How long does 7-OH stay in your system?
Detection depends entirely on which test is used, since routine panels do not look for it at all. Ask the ordering clinician or the laboratory which assay they run and what its detection window is.
Does insurance cover Suboxone treatment?
Coverage varies by plan and by state. Porch Light Health accepts Medicaid and Medicare along with major commercial insurers, and our team can walk you through your specific benefits before your first visit.
What if I am pregnant and have been using 7-OH?
Tell your clinician and your obstetric provider as early as you can. Medication treatment during pregnancy is generally continued rather than stopped, and care is coordinated between both teams.
Can I start treatment by telehealth?
Often yes. Rules differ by state and by clinical circumstance, and your care team will tell you whether an in-person visit or a local lab collection is needed first.
What should I bring to my first appointment?
A photo ID, a list of your current medications with doses, any recent lab or pharmacy records, and your insurance card if you have one.
You do not need a clean test, a perfect story, or a plan to call. You need a phone.
Call 866-839-8868 to speak with our team, or contact Porch Light Health and we will reach out. You can also find a clinic near you across Colorado and New Mexico, including mobile sites and telehealth.
